Tradestie Institutional Equity Comparison Engine · Market Close Nov 19, 2026

RYOJ vs SBC: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

SBC Wins Head-to-Head Institutional Verdict (4–1 across 6 Pillars · 8–2 Matrix Metrics)

SBC Overall Winner 6-Pillar Tally: RYOJ 1 – 4 SBC (1 Tie) Matrix Metrics: RYOJ 2 – 8 SBC

As of Nov 19, 2026, SBC Medical Group Holdings Incorporated (SBC) is the stronger overall head-to-head candidate over rYojbaba Co., Ltd. Common Shares (RYOJ) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 4–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). RYOJ carries a Unified Composite Score of 42.9/100 (HOLD) at $2.23 (N/M Forward P/E, -8.1% operating margin), whereas SBC carries 38.7/100 (SELL) at $5.60 (10.2x Forward P/E, 39.9% operating margin).

  • Composite vs. Pillar Nuance: While RYOJ currently prints a higher short-term Unified Composite Score (42.9/100 HOLD vs. SBC 38.7/100 SELL), SBC captures the overall institutional head-to-head verdict (8–2 matrix metrics and 4–1 across the 6 pillars) due to superior fundamental profitability (39.9% vs. -8.1% operating margin) and revenue trajectory (+35.1% vs. -34.3% YoY).
  • Technical & Structure Timing Caution: RYOJ is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 37.3); meanwhile SBC trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 50.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About RYOJ vs SBC
RYOJ NASDAQ
rYojbaba Co., Ltd. Common Shares
Services-Management Consulting Services
$2.23
-0.89% 1D
Market Cap $26.0M
TTM Revenue $9.3M
Forward P/E N/M
Beta / 30D Vol 1.68β · 92% Vol
Unified Composite Score
42.9 / 100 HOLD
Tech 23.0 Fund 50.0 Flow 50.0 Mom 64.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -26.4%), weak momentum, RSI 37
RSI-14: 37.3 · SMA20: $2.45 · SMA50: $2.95
SBC NASDAQ Head-to-Head Winner
SBC Medical Group Holdings Incorporated Common Stock
Services-Offices & Clinics Of Doctors Of Medicine
$5.60
-10.69% 1D
Market Cap $643.2M
TTM Revenue $190M
Forward P/E 10.2x
Beta / 30D Vol 0.80β · 156% Vol
Unified Composite Score
38.7 / 100 SELL
Tech 15.0 Fund 29.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (13.1% over 20 days), RSI 51
RSI-14: 50.8 · SMA20: $5.54 · SMA50: $5.26

6-Pillar Scorecard Institutional Category Breakdown (RYOJ 1 – 4 SBC)

Columns: Metric · RYOJ · SBC
1. Valuation Multiples SBC
Forward P/E N/M 10.2x
Trailing P/E N/M 12.3x
PEG Ratio N/M 2.35x
EV / Revenue 2.8x 3.4x
2. Growth & Scale SBC
Revenue Growth (YoY) -34.3% +35.1%
Earnings Growth (YoY) +11.8% +22.4%
TTM Revenue (USD) $9.3M $190M
Market Cap $26.0M $643.2M
3. Profitability & Quality SBC
Gross Margin 26.6% 72.2%
Operating Margin -8.1% 39.9%
Net Profit Margin 1.3% 27.3%
Return on Equity (ROE) 2.8% 19.3%
4. Balance Sheet & Cash Flow SBC
Cash Generation (TTM) -$59,921 EBITDA $80M EBITDA
Cash Flow Margin -0.6% EBITDA Mgn 41.8% EBITDA Mgn
Net Cash / Leverage $0.53 Book/Sh · 2.8% ROE $2.79 Book/Sh · 19.3% ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Markdown NEUTRAL · Markup
6. R&D & Supply-Chain Moat RYOJ
OpEx & R&D Intensity 34.7% of Rev ($3.2M) 32.3% of Rev ($61M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning High-Margin Pricing Power Moat
Supply-Chain Role Consulting Services Operator Consulting Services Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: RYOJ (2) vs SBC (8)
Institutional Metric RYOJ SBC Criterion Row Edge
Market Capitalization
Scale
$26.0M $643.2M Larger Scale SBC
Trailing P/E Ratio
Valuation
N/M 12.3x Lower Multiple SBC
Forward P/E Ratio
Valuation
N/M 10.2x Lower Multiple SBC
Revenue Growth (YoY)
Growth
-34.3% +35.1% Higher Growth SBC
Operating Margin (TTM)
Profitability
-8.1% 39.9% Higher Margin SBC
Net Profit Margin
Profitability
1.3% 27.3% Higher Margin SBC
Return on Equity (ROE)
Capital Efficiency
2.8% 19.3% Higher ROE SBC
52-Week Range Position
Momentum
10% ($2–$8) 61% ($3–$7) Stronger Trend SBC
Beta / 30D Volatility
Risk Regime
1.68β · 92% Vol 0.80β · 156% Vol Lower Realized Risk RYOJ
Unified Institutional Score
Composite Signal
42.9 / 100 (HOLD) 38.7 / 100 (SELL) Higher Composite RYOJ
Trailing 12M Revenue (USD)
Operating Scale
$9.3M $190M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
26.6% 72.2% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 2.8x EV/Rev 2.35x PEG · 3.4x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$59,921 EBITDA ($0.53 Book/Sh · 2.8% ROE) $80M EBITDA ($2.79 Book/Sh · 19.3% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon SBC +12.59 pp
RYOJ: -11.51% · SBC: +1.08%
3M Horizon SBC +104.83 pp
RYOJ: -52.66% · SBC: +52.17%
6M Horizon SBC +59.6 pp
RYOJ: +13.77% · SBC: +73.37%
1Y Horizon SBC +126.32 pp
RYOJ: -49.66% · SBC: +76.66%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on RYOJ vs SBC. Trailing 12-month operating profitability (RYOJ -8.1% vs SBC 39.9%) and valuation multiples (RYOJ N/M vs SBC 10.2x Forward P/E) are benchmarked directly in Pillar 4 below.

RYOJ ADR TTM Benchmark FX-Normalized USD
TTM Revenue$9.3M
Gross Margin26.6%
Op. Margin-8.1%
ROE / Fwd P/E2.8% · N/M
SBC ADR TTM Benchmark FX-Normalized USD
TTM Revenue$190M
Gross Margin72.2%
Op. Margin39.9%
ROE / Fwd P/E19.3% · 10.2x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
RYOJ UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact RYOJ Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
SBC UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact SBC Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
RYOJ Moat Profile Cyclical / Execution-Driven Positioning
Consulting Services Operator
Competes within the Consulting Services value chain with $26.0M market capitalization and -8.1% operating margin.
OpEx & R&D Reinvestment 34.7% of Rev ($3.2M)
90D Engineering Disclosures 0 Published
SBC Moat Profile High-Margin Pricing Power Moat
Consulting Services Operator
Competes within the Consulting Services value chain with $643.2M market capitalization and 39.9% operating margin.
OpEx & R&D Reinvestment 32.3% of Rev ($61M)
90D Engineering Disclosures 0 Published

Investor FAQ RYOJ vs SBC Key Questions & Quantitative Answers

As of Nov 19, 2026, SBC Medical Group Holdings Incorporated (SBC) is the stronger overall head-to-head candidate over rYojbaba Co., Ltd. Common Shares (RYOJ) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 4–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). RYOJ carries a Unified Composite Score of 42.9/100 (HOLD) at $2.23 (N/M Forward P/E, -8.1% operating margin), whereas SBC carries 38.7/100 (SELL) at $5.60 (10.2x Forward P/E, 39.9% operating margin). Composite vs. Pillar Nuance: While RYOJ currently prints a higher short-term Unified Composite Score (42.9/100 HOLD vs. SBC 38.7/100 SELL), SBC captures the overall institutional head-to-head verdict (8–2 matrix metrics and 4–1 across the 6 pillars) due to superior fundamental profitability (39.9% vs. -8.1% operating margin) and revenue trajectory (+35.1% vs. -34.3% YoY). Technical & Structure Timing Caution: RYOJ is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 37.3); meanwhile SBC trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 50.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

SBC leads the Growth & Scale pillar: RYOJ posts -34.3% YoY revenue growth and +11.8% YoY earnings growth on $9.3M TTM revenue (26.6% gross margin, -8.1% operating margin), compared with SBC at +35.1% YoY revenue growth and +22.4% YoY earnings growth on $190M TTM revenue (72.2% gross margin, 39.9% operating margin). On trailing 12-month operating scale, RYOJ generates $9.3M in USD-normalized revenue versus $190M for SBC. In operating R&D and SG&A reinvestment, RYOJ deploys 34.7% of Rev ($3.2M) (0 90-day corporate R&D disclosures) versus 32.3% of Rev ($61M) (0 disclosures) for SBC.

SBC screens cheaper on headline valuation multiples. RYOJ trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 2.8x EV/Revenue (-0.6% EBITDA margin), whereas SBC trades at 10.2x Forward P/E, 12.3x Trailing P/E, 2.35x PEG, and 3.4x EV/Revenue (41.8% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against RYOJ (2.8% ROE) versus SBC (19.3% ROE) capital efficiency.

In options market volatility and institutional positioning, RYOJ carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.68β · 92% Vol realized risk). By comparison, SBC carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.80β · 156% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 19, 2026. For educational research only; not investment advice.